Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome

Atypical hemolytic uremic syndrome (aHUS) is a rare cause of end-stage kidney disease and associated with poor outcomes after kidney transplantation from early disease recurrence. Prophylactic eculizumab treatment at the time of transplantation is used in selected patients with aHUS. We report a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Glover, Emily K., Smith-Jackson, Kate, Brocklebank, Vicky, Wilson, Valerie, Walsh, Patrick R., Montgomery, Emma K., Wong, Edwin K.S., Johnson, Sally, Malina, Michal, Kavanagh, David, Sheerin, Neil S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065821/
https://www.ncbi.nlm.nih.gov/pubmed/36413152
http://dx.doi.org/10.1097/TP.0000000000004355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065821/
https://www.ncbi.nlm.nih.gov/pubmed/36413152
http://dx.doi.org/10.1097/TP.0000000000004355

Ejemplares similares